Dr Reddys Laboratories (RDY) Interest Coverage Ratio Growth (3y) (2012 - 2026)
Powered by 
Analysis
Dr Reddys Laboratories (RDY) Interest Coverage Ratio Growth (3y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn | - |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | -72.71% |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn | -40.53% |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | - |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn | 13.10% |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | -55.02% |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | - |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn | -16.49% |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | 370.83% |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 40.53% |
| Mar 31, 2026 | 26.00% |
| Dec 31, 2025 | 26.23% |
| Sep 30, 2025 | -29.92% |
| Jun 30, 2025 | 15.74% |
| Mar 31, 2025 | 27.33% |
| Dec 31, 2024 | 4.33% |
| Sep 30, 2024 | 15.65% |
| Jun 30, 2024 | 21.63% |
| Mar 31, 2024 | -4.91% |
| Dec 31, 2023 | -2.36% |
| Sep 30, 2023 | -78.72% |
| Jun 30, 2023 | 27.24% |
| Mar 31, 2023 | 12.07% |
| Dec 31, 2022 | 28.47% |
| Sep 30, 2022 | 76.83% |
| Jun 30, 2022 | -13.36% |
| Mar 31, 2022 | 39.60% |
| Dec 31, 2021 | -72.04% |
| Jun 30, 2021 | -100.06% |